Trademark: 97338000
Word
SIROGEN
Status Date
Wednesday, May 29, 2024
Filing Date
Wednesday, March 30, 2022
Published for Opposition
Tuesday, April 4, 2023
5 A combination drug product, namely, a pharmaceutical ingredient in the nature of a formulation of sirolimus incorporated within a collagen membrane, which, an implantable drug carrier, enables local delivery of sirolimus to the vascular wall, administered by physicians during surgery
Jan 17, 2023
Assigned To Examiner
Apr 2, 2022
New Application Entered
Apr 4, 2022
New Application Office Supplied Data Entered
Jan 20, 2023
Non-Final Action Written
Jan 20, 2023
Non-Final Action E-Mailed
Jan 20, 2023
Notification Of Non-Final Action E-Mailed
Feb 7, 2023
Teas Response To Office Action Received
Feb 7, 2023
Correspondence Received In Law Office
Feb 8, 2023
Teas/Email Correspondence Entered
Feb 27, 2023
Approved For Pub - Principal Register
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 4, 2023
Published For Opposition
Nov 22, 2023
Sou Teas Extension Received
Nov 22, 2023
Sou Extension 1 Filed
Nov 22, 2023
Sou Extension 1 Granted
Nov 24, 2023
Notice Of Approval Of Extension Request E-Mailed
May 29, 2024
Sou Teas Extension Received
May 29, 2024
Sou Extension 2 Filed
May 29, 2024
Sou Extension 2 Granted
May 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
